Insider Trades31 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Sell | GLUE | Markus Warmuth | President & CEO | 9,500 | $23.18 | $2.1B | -4.70% | +496.12% | $220.2K | -1.60% | — | Buy Now |
| Jul 15, 2026 | Sell | GLUE | Jennifer Champoux | Chief Operating Officer | 8,702 | $13.68 | $2.1B | -4.70% | +496.12% | $119.0K | +0.00% | 10b5-1 | Buy Now |
| Jul 6, 2026 | Sell | GLUE | Sharon Townson | Chief Scientific Officer | 12,000 | $14.72 | $2.1B | -4.70% | +496.12% | $176.7K | +0.00% | 10b5-1 | Buy Now |
| Jun 30, 2026 | Sell | GLUE | Filip Janku | Chief Medical Officer | 10,814 | $18.95 | $2.1B | -4.70% | +496.12% | $205.0K | +0.00% | 10b5-1 | Buy Now |
| Jun 29, 2026 | Sell | GLUE | Filip Janku | Chief Medical Officer | 12,000 | $15.26 | $2.1B | -4.70% | +496.12% | $183.1K | +0.00% | 10b5-1 | Buy Now |
| Jun 23, 2026 | Sell | GLUE | Jennifer Champoux | Chief Operating Officer | 4,350 | $11.99 | $2.1B | -4.70% | +496.12% | $52.2K | +0.00% | 10b5-1 | Buy Now |
| Jun 23, 2026 | Sell | GLUE | Sharon Townson | Chief Scientific Officer | 6,000 | $13.07 | $2.1B | -4.70% | +496.12% | $78.4K | +0.00% | 10b5-1 | Buy Now |
| Jun 23, 2026 | Sell | GLUE | Filip Janku | Chief Medical Officer | 77,845 | $14.83 | $2.1B | -4.70% | +496.12% | $1.2M | -1.30% | 10b5-1 | Buy Now |
| Jun 17, 2026 | Sell | GLUE | Jennifer Champoux | Chief Operating Officer | 4,352 | $11.49 | $2.1B | -4.70% | +496.12% | $50.0K | +0.00% | 10b5-1 | Buy Now |
| Jun 17, 2026 | Sell | GLUE | Sharon Townson | Chief Scientific Officer | 6,000 | $12.57 | $2.1B | -4.70% | +496.12% | $75.4K | +0.00% | 10b5-1 | Buy Now |
| Jun 1, 2026 | Sell | GLUE | Markus Warmuth | President & CEO | 5,466 | $19.44 | $2.1B | -4.70% | +496.12% | $106.3K | -0.46% | 10b5-1 | Buy Now |
| May 29, 2026 | Sell | GLUE | Sharon Townson | Chief Scientific Officer | 12,000 | $13.01 | $2.1B | -4.70% | +496.12% | $156.1K | +0.00% | 10b5-1 | Buy Now |
| May 27, 2026 | Sell | GLUE | Jennifer Champoux | Chief Operating Officer | 4,350 | $11.99 | $2.1B | -4.70% | +496.12% | $52.2K | +0.00% | 10b5-1 | Buy Now |
| May 22, 2026 | Sell | GLUE | Jennifer Champoux | Chief Operating Officer | 4,352 | $11.49 | $2.1B | -4.70% | +496.12% | $50.0K | +0.00% | 10b5-1 | Buy Now |
| May 1, 2026 | Sell | GLUE | Markus Warmuth | President & CEO | 5,467 | $18.92 | $2.1B | -4.70% | +496.12% | $103.4K | -0.90% | 10b5-1 | Buy Now |
| Apr 14, 2026 | Sell | GLUE | Markus Warmuth | President & CEO | 8,000 | $17.64 | $2.1B | -4.70% | +496.12% | $141.1K | -1.30% | — | Buy Now |
| Apr 9, 2026 | Sell | GLUE | Philip Nickson | Chief Business & Legal Officer | 5,845 | $17.69 | $2.1B | -4.70% | +496.12% | $103.4K | -9.61% | — | Buy Now |
| Mar 4, 2026 | Sell | GLUE | Edmund Dunn | Principal Accounting Officer | 139 | $17.96 | $2.1B | -4.70% | +496.12% | $2.5K | -0.61% | — | Buy Now |
| Mar 2, 2026 | Sell | GLUE | Markus Warmuth | President & CEO | 5,466 | $17.92 | $2.1B | -4.70% | +496.12% | $98.0K | -0.88% | 10b5-1 | Buy Now |
| Feb 27, 2026 | Sell | GLUE | Edmund Dunn | Principal Accounting Officer | 51,400 | $15.75 | $2.1B | -4.70% | +496.12% | $809.5K | +0.00% | — | Buy Now |
| Feb 23, 2026 | Sell | GLUE | Filip Janku | Chief Medical Officer | 9,189 | $19.50 | $2.1B | -4.70% | +496.12% | $179.2K | -12.25% | — | Buy Now |
| Jan 7, 2026 | Sell | GLUE | Markus Warmuth | President & CEO | 5,466 | $23.49 | $2.1B | -4.70% | +496.12% | $128.4K | -0.29% | 10b5-1 | Buy Now |
| Jan 5, 2026 | Sell | GLUE | Edmund Dunn | Principal Accounting Officer | 1,039 | $15.17 | $2.1B | -4.70% | +496.12% | $15.8K | -4.38% | — | Buy Now |
| Jan 5, 2026 | Sell | GLUE | Jennifer Champoux | Chief Operating Officer | 2,629 | $15.17 | $2.1B | -4.70% | +496.12% | $39.9K | -1.18% | — | Buy Now |
| Jan 5, 2026 | Sell | GLUE | Sharon Townson | Chief Scientific Officer | 3,155 | $15.17 | $2.1B | -4.70% | +496.12% | $47.9K | -1.38% | — | Buy Now |
| Jan 5, 2026 | Sell | GLUE | Filip Janku | Chief Medical Officer | 3,155 | $15.17 | $2.1B | -4.70% | +496.12% | $47.9K | -1.45% | — | Buy Now |
| Jan 5, 2026 | Sell | GLUE | Philip Nickson | Chief Business & Legal Officer | 3,155 | $15.17 | $2.1B | -4.70% | +496.12% | $47.9K | -1.66% | — | Buy Now |
| Jan 5, 2026 | Sell | GLUE | Markus Warmuth | President & CEO | 10,135 | $15.17 | $2.1B | -4.70% | +496.12% | $153.7K | -0.97% | — | Buy Now |
| Jun 3, 2025 | Sell | GLUE | Edmund Dunn | Principal Accounting Officer | 2,062 | $4.45 | $2.1B | -4.70% | +496.12% | $9.2K | -7.99% | — | Buy Now |
| Jul 5, 2024 | Sell | GLUE | Edmund Dunn | Principal Accounting Officer | 1,610 | $3.83 | $2.1B | -4.70% | +496.12% | $6.2K | -10.35% | — | Buy Now |
| Jun 3, 2024 | Sell | GLUE | Edmund Dunn | Principal Accounting Officer | 1,207 | $4.04 | $2.1B | -4.70% | +496.12% | $4.9K | -7.20% | — | Buy Now |